Mayumi Terada

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS.

Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS.

Journal: Vaccine

Published: November 27, 2025

Is Short-term Antimicrobial Administration Sufficient? The Need for Considering Information on Infection-Related Variables and the Target Population.

Is Short-term Antimicrobial Administration Sufficient? The Need for Considering Information on Infection-Related Variables and the Target Population.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 18, 2024

Corrigendum: Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis.

Corrigendum: Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis.

Journal: Frontiers in immunology

Published: August 09, 2023

Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis.

Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis.

Journal: Frontiers in immunology

Published: May 14, 2023

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).

Journal: Expert review of vaccines

Published: March 08, 2023

Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).

Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 14, 2022

Respiratory virus detection in the upper respiratory tract of asymptomatic, community-dwelling older people.

Respiratory virus detection in the upper respiratory tract of asymptomatic, community-dwelling older people.

Journal: BMC infectious diseases

Published: June 10, 2021

The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan.

The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan.

Journal: Vaccine

Published: December 03, 2019

Defective efferocytosis by alveolar macrophages in IPF patients.

Defective efferocytosis by alveolar macrophages in IPF patients.

Journal: Respiratory medicine

Published: July 13, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026